Kenvue's improvements in marketing and management could drive future growth. Read why there is potential for a turnaround for ...

Jefferies analyst Keith Devas revised the price target for Kenvue Inc (NYSE: NYSE:KVUE) shares, lowering it to $26.00 from the previous $27.00 while sustaining a Buy rating on the stock. According to ...

Aid, reported sales that missed analyst estimates after weaker-than-expected volumes hurt results. The key measure of organic ...

Consumer health company Kenvue forecast 2025 adjusted profit below Wall Street estimates on Thursday, hit by a stronger ...

has been under pressure from activist Starboard Value to improve performance, especially at its skin and beauty products ...

Health-care companies rose after strong earnings from one major drug maker. Novo Nordisk shares rose sharply after the Danish obesity-drug maker posted fourth-quarter Ozempic sales of $4.71 billion, ...

The world's largest mattress supplier and manufacturer said its Mattress Firm, Dreams and Tempur Sealy businesses will operate as decentralized units under the Somnigroup umbrella after the name ...

Kenvue (KVUE) issued the following statement in response to Starboard Value’s submission of four nominees to stand for election to the Kenvue ...

EST Kenvue (KVUE) confirms receipt of director nominees from Starboard ValueMaximize Your Portfolio with Data Driven Insights:Leverage ...

("Kenvue"), the world’s largest pure-play consumer health company by revenue, today issued the following statement in response to Starboard Value’s ("Starboard") submission of four nominees to stand ...

Hedge fund Starboard Value has nominated four directors, including its chief investment officer, to the board of consumer ...

Kenvue Inc. (KVUE) confirms receipt of activist Starboard Value's board nominees, aiming to unlock company's potential and ...